Detection of SARS-CoV-2 Neutralizing Antibodies with GenScript's Surrogate Virus Neutralization Test

Explore the challenges of SARS-CoV-2 vaccine efficacy testing and the importance of neutralizing antibodies in this 18-minute webinar presented by Amanda Grimm, Senior Segment Market Manager at GenScript. Delve into the correlation between neutralizing antibody titers and protection against COVID-19, examining recent studies on vaccine effectiveness in elderly and immunocompromised populations. Learn about waning immunity, breakthrough infections, and the impact of new variants like Omicron and Delta. Discover how surrogate virus neutralization testing (sVNT) can help determine individual needs for booster shots and assess protection against COVID-19 variants of concern. Gain valuable insights into the healthcare implications of SARS-CoV-2 and the role of neutralizing antibody testing in managing the ongoing pandemic.